Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03391700Unknown
Open-label trial of rocuronium (2 arms), sponsored by SMG-SNU Boramae Medical Center. Primary endpoint: Overall incidence of postoperative sore throat at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03391700.